• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

0.00 0.00 (0.00%)

REAL-TIME: Last trade at

PRESSURE BIOSCIENCES, INC.

NASDAQ:PBIO

Jump to this page for:

Related Resources

Pressure BioSciences, LEAP Technologies, Sage-N Research, and Valco Instruments Announce Plans to Co-Develop Next Generation Sample Preparation/Data Analysis Platform for H/D Exchange Mass Spectrometry

5/21/2012 by MacReport.Net

Pressure BioSciences, LEAP Technologies, Sage-N Research, and Valco Instruments Announce Plans to Co-Develop Next Generation Sample Preparation/Data Analysis Platform for H/D Exchange Mass Spectrometry

5/21/2012 by PR Newswire

Pressure BioSciences, Inc. Reports 69% Revenue Increase for Q1 2012

5/16/2012 by MacReport.Net

Pressure BioSciences, Inc. Reports 69% Revenue Increase for Q1 2012

5/16/2012 by Marketwire

Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update

5/15/2012 by MacReport.Net

Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update

5/15/2012 by PR Newswire

Pressure BioSciences, Inc. and LEAP Technologies, Inc. Announce Co-Development, Co-Marketing, & Co-Selling Agreement

5/7/2012 by MacReport.Net

Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDI's Planned Offering of Personalized Medicine Clinical Diagnostic Services

4/23/2012 by MacReport.Net

Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDI's Planned Offering of Personalized Medicine Clinical Diagnostic Services

4/23/2012 by PR Newswire

Pressure BioSciences, Target Discovery expand strategic license agreement

4/23/2012 by Theflyonthewall.com

Pressure BioSciences Has Landed a Favorable Financing Deal

4/18/2012 by Zacks Equity Research Analyst Blog

Pressure BioSciences Has Landed a Favorable Financing Deal - Analyst Blog

4/18/2012 by Zacks Investment Research

Pressure BioSciences to Receive $500,000 Investment from Ironridge BioPharma

4/9/2012 by GenomeWeb

Ironridge BioPharma to invest $500,000 in Pressure BioSciences

4/9/2012 by Theflyonthewall.com

Ironridge BioPharma to Invest $500,000 in Pressure BioSciences

4/9/2012 by GlobeNewswire

Pressure BioSciences Common Stock to Begin Trading Today on the OTCQB(TM) Tier of the OTC Marketplace

4/5/2012 by GlobeNewswire

Pressure BioSciences and Sage-N Research to Collaborate on Improving the Extraction and Analysis of Integral Cell Membrane Proteins That May be Associated With Cancer, Stroke, and Other Diseases and Disorders

3/19/2012 by StockWatch

Pressure BioSciences, Sage-N Research to collaborate to develop applications

3/19/2012 by Theflyonthewall.com

Pressure BioSciences and Sage-N Research to Collaborate on Improving the Extraction and Analysis of Integral Cell Membrane Proteins That May be Associated With Cancer, Stroke, and Other Diseases and Disorders

3/19/2012 by GlobeNewswire

RocketAlerts.com Daily Winners: Titan Iron Ore Corp. (TFER) and Pressure BioSciences Inc. (PBIO). Get in, get out but don't stick around.

3/15/2012 by Marketwire

Nasdaq Extends Deadlines for Pressure BioSciences to Regain Listing Compliance

3/9/2012 by GenomeWeb

Dr. Henry C. Lee, One of the World's Leading Forensic Scientists, to Investigate the Use of Pressure BioSciences' Enabling Pressure Cycling Technology ("PCT") Platform for Use in Multiple Areas of Forensic Analysis

3/9/2012 by GlobeNewswire

NASDAQ Panel Grants Pressure BioSciences' Request for Continued Listing Pursuant to an Extension

3/8/2012 by GlobeNewswire

New Data Indicate Pressure BioSciences' Novel Technology Platform Offers Great Promise to the Areas of Biomarker Discovery and Drug Development

3/7/2012 by GlobeNewswire

Pressure BioSciences announces distribution agreement for the Benelux Countries

3/1/2012 by Theflyonthewall.com

Pressure BioSciences, Inc. Continues Expansion of European Sales Reach With Distribution Agreement for the Benelux Countries

3/1/2012 by GlobeNewswire

Pressure BioSciences, Inc. to Discuss Fourth Quarter and FY2011 Financial Results and Provide Busin

2/29/2012 by NASDAQ

Pressure BioSciences Q4 Revenues Rise 22 Percent, But Says Cash Lasts Only Until April

2/28/2012 by GenomeWeb

Pressure BioSciences, Inc. Reports 2011 Financial Results

2/28/2012 by StockWatch

Pressure BioSciences, Inc. Reports 2011 Financial Results

2/28/2012 by GlobeNewswire

Pressure BioSciences CEO: sees firm's momentum continuing to build in 2012

2/27/2012 by Theflyonthewall.com

CEO of Pressure BioSciences Sees Firm's Momentum Continuing to Build in 2012

2/27/2012 by StockWatch

CEO of Pressure BioSciences Sees Firm's Momentum Continuing to Build in 2012

2/27/2012 by Marketwire

Pressure BioSciences, Inc. Closes $800,000 Private Placement

2/8/2012 by StockWatch

Pressure BioSciences, Inc. Closes $800,000 Private Placement

2/8/2012 by GlobeNewswire

Pressure BioSciences Reports Significant Progress in the Development of a PCT-based Method to Improve Processing of Sexual Assault Samples

1/25/2012 by Pharmaceutical and Medical Packaging News

Pressure BioSciences Reports Significant Progress in the Development of a PCT-based Method to Impro

1/25/2012 by NASDAQ

Pressure BioSciences reports progress in PCT method in assualt cases samples

1/25/2012 by Theflyonthewall.com

Pressure BioSciences Reports Significant Progress in the Development of a PCT-based Method to Improve Processing of Sexual Assault Samples

1/25/2012 by GlobeNewswire

Pressure BioSciences, Inc. Announces Global Co-Marketing/Selling and Instrument Co-Development Agreement With Digilab, Inc.

1/11/2012 by StockWatch
See More Articles...